Efentakis P, Varela A, Sigala F, Kostomitsopoulos N, Tenta R, Gioti K, Parissis J, Farmakis D, Iliodromitis EK, Papapetropoulos A, et al. Levosimendan protects against doxorubicin induced acute cardiotoxicity by regulation of oxidative stress and by activation of antiapoptotic mechanisms. In: EUROPEAN HEART JOURNAL. Vol. 37. OXFORD UNIV PRESS GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND; 2016. pp. 117–117.